Science Update: Naltrexone Could Hold Promise for Treating Opioid Use Disorder During Pregnancy, NICHD-funded Study Suggests
August 26, 2019
August 26, 2019
ROCKVILLE, Maryland, Aug. 26 -- The Eunice Kennedy Shriver National Institute of Child's Health and Human Development issued the following science update:
Infants born to mothers taking the drug naltrexone to treat opioid use disorder showed no signs of drug withdrawal and had shorter hospital stays than infants born to mothers undergoing the standard treatment, according to a small study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.< . . .
Infants born to mothers taking the drug naltrexone to treat opioid use disorder showed no signs of drug withdrawal and had shorter hospital stays than infants born to mothers undergoing the standard treatment, according to a small study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.< . . .